Role of prolyl isomerase Pin1 in pathogenesis of diseases and remedy for the diseases from natural products

Current Drug Targets

Volumn 15, Issue 10, 2014, Pages 973-981

  Takahashi, Katsuhiko ^a,b   Shimizu, Taiki ^a   Kosaka, Keita ^a   Hidaka, Masafumi ^a   Uchida, Chiyoko ^a,c   Uchida, Takafumi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c FUKUSHIMA UNIVERSITY   (Japan)

Author keywords

Inhibitor; Natural products; Pin1; Screening

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ALPHA SYNUCLEIN; APOLIPOPROTEIN B; EPIGALLOCATECHIN GALLATE; HEPATITIS B VIRUS X PROTEIN; INTERLEUKIN 5; JUGLONE; NATURAL PRODUCT; PEPTICINNAMIN E; PEPTIDYLPROLYL ISOMERASE PIN1; PHLOROTANNIN; POLYHYDROXYPHENOL DERIVATIVE; POLYPHENOL DERIVATIVE; PYRUVATE DEHYDROGENASE KINASE 2; RNA POLYMERASE; UNCLASSIFIED DRUG; BIOLOGICAL PRODUCT; ENZYME INHIBITOR; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ARTICLE; ASTHMA; CARCINOGENESIS; ENZYME ACTIVITY; HEPATITIS B VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; NEOPLASM; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; T LYMPHOCYTE; TRADITIONAL MEDICINE; VIRUS INFECTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; IMMUNE SYSTEM DISEASES; METABOLISM; NEOPLASMS; PATHOLOGY;

ALZHEIMER DISEASE; ANIMALS; BIOLOGICAL PRODUCTS; ENZYME INHIBITORS; HUMANS; IMMUNE SYSTEM DISEASES; NEOPLASMS; PARKINSON DISEASE; PEPTIDYLPROLYL ISOMERASE;

EID: 84925947266     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Lang K, Schmid FX, Fischer G. Catalysis of protein folding by prolyl isomerase. Nature 1987; 329: 268-70.
2. Göthel SF, Marahiel MA. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol Life Sci 1999; 55: 423-36.
3. Barik S. Immunophilins: for the love of proteins. Cell Mol Life Sci 2006; 63: 2889-900.
4. Lu KP, Hanes SD, Hunter T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996; 380: 544-7.
5. Hanes SD. The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle. Biochem Biophys Acta 2014; 1839: 316-33.
6. Lu KP, Zhou XZ. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol 2007; 8: 904-16.
7. Shen M, Stukenberg PT, Kirschner MW, et al. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosisspecific phosphoproteins. Genes Dev 1998; 12: 706-720.
8. Lu PJ, Zhou XZ, Shen M, et al. Function of WW domains as phosphoserine-or phosphothreonine-binding modules. Science 1999; 283: 1325-8.
9. Ranganathan R, Lu KP, Hunter T, et al. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997; 89: 875-86.
10. Takahashi K, Uchida C, Shin R-W, et al. New findings of prolyl isomerase Pin1: Post-translational modifications of Pin1 and its physiological substrates implicated in the pathogenesis of cancer, Alzheimer's disease and asthma. Cell Mol Life Sci 2008; 65: 359-75.
11. Fujimori F, Takahashi K, Uchida C, et al. Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. Bioche Biophy Res Commun 1999; 265: 658-63.
12. Liou YC, Ryo A, Huang HK, et al. Loss of Pin1 function in the mouse causes phenotypes resemble cyclin D1-null phenotypes. Proc Natl Acad Sci USA 2002; 99: 1335-40.
13. Atchison FW, Capel B, Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 2003; 130: 3579-86.
14. Atchison FW, Means AR, Spermatogonial depletion in adult Pin1-deficient mice. Biol Reprod 2003; 69: 1989-97.
15. Wulf GM, Ryo A, Wulf GG, et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J 2001; 20: 3459-72.
16. Lee TH, Tun-Kyi A, Shi R, et al. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat Cell Biol 2009; 11: 97-105.
17. Liou YC, Sun A, Ryo A, et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003; 424: 556-61.
18. Akiyama H, Shin RW, Uchida C, et al. Pin1 promotes production of Alzheimer's amyloid beta from beta-cleaved amyloid precursor protein. Biochem Biophys Res Commun 2005; 336: 521-9.
19. Pastorino L, Sun A, Lu PJ, et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006; 440: 528-34.
20. Sultana R, Boyd-Kimball D, Poon HF, et al. Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis. Neurobiol Aging 2006; 27: 918-25.
21. Butterfield DA, Poon HF, St Clair D, et al. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis 2006; 22: 223-32.
22. Suizu F, Ryo A, Wulf G, et al. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol Cell Biol 2006; 26: 1463-79.
23. Theuerkorn M, Fischer G, Schiene-Fischer C, Prolyl cis/trans isomerase signaling pathways in cancer. Curr Opin Pharmacol 2011; 11: 281-7.
24. Dong L, Marakovits J, Hou X, et al. Structure-based design of novel human Pin1 inhibitors (II). Bioorg Med Chem Lett 2010; 20: 2210-4.
25. Potter A, Oldfield V, Nunns C, et al. Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. Bioorg Med Chem Lett 2010; 20: 6483-8.
26. Zhu L, Jin J, Liu C, et al. Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors. Bioorg Med Chem 2011; 19: 2797-807.
27. Duncan KE, Dempsey BR, Killip LE, et al. Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1. J Med Chem 2011; 54: 3854-65.
28. Liu C, Jin J, Chen L, et al. Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton. Bioorg Med Chem 2012; 20: 2992-9.
29. Xu GG, Slebodnick C, Etzkorn FA, Cyclohexyl ketone inhibitors of Pin1 dock in a trans-diaxial cyclohexane conformation. PLoS One 2012; 7: e44226.
30. Moore JD, Potter A, Pin1 inhibitors: Pitfalls, progress and cellular pharmacology. Bioorg Med Chem Lett 2013; 23: 4283-91.
31. Ghosh A, Saminathan H, Kanthasamy A, et al. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease. J Biol Chem 2013; 288: 21955-71.
32. Shen ZJ, Esnault S, Malter JS, The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colonystimulating factor mRNA in activated eosinophils. Nat Immunol 2005; 6: 1280-7.
33. Esnault S, Rosenthal LA, Shen ZJ, et al. A critical role for Pin1 in allergic pulmonary eosinophilia in rats. J Allergy Clin Immunol 2007; 120: 1082-8.
34. Shen ZJ, Esnault S, Rosenthal LA, et al. Pin1 regulates TGF-beta1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J Clin Invest 2008; 118: 479-90.
35. Watashi K, Khan M, Yedavalli VR, et al. Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J Virol 2008; 82: 9928-36.
36. Manganaro L, Lusic M, Gutierrez MI, et al. Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes. Nat Med 2010; 16: 329-33.
37. Misumi S, Inoue M, Dochi T, et al. Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. J Biol Chem 2010; 285: 25185-95.
38. Nakatsu Y, Otani Y, Sakoda H, et al. Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model. J Biol Chem 2012; 287: 44526-35.
39. Harvey AL. Natural products as a screening resource. Curr Opin Chem Biol 2007; 11: 480-4.
40. "Using Old Solutions to New Problems-Natural Drug Discovery in the 21st Century", book edited by Marianna Kulka, ISBN 978-953-51-1158-0, Published: June 19, 2013 under CC BY 3. 0 license Discovery, Development, and Regulation of Natural Products By Juergen Krause and Gailene Tobin.
41. Li JW, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science 2009; 325: 161-5.
42. Mori T, Hidaka M, Lin YC, et al. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method. Biochem Biophys Res Commun 2011; 406: 439-43.
43. Mori T, Hidaka M, Ikuji H, et al. A high-throughput screen for inhibitors of the prolyl isomerase, Pin1, identified a seaweed polyphenol that reduces adipose cell differentiation. Biosci Biotechnol Biochem 2014; 78: 832-8.
44. Yeh ES, Means AR. PIN1, the cell cycle and cancer. Nat Rev Cancer 2007; 7: 381-8.
45. Finn G, Lu KP, Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer. Curr Cancer Drug Targets 2008; 8: 223-9.
46. Bao L, Kimzey A, Sauter G, et al. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am J Patho 2004; 164: 1727-37.
47. Yang W, Zheng Y, Xia Y, et al. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect. Nat Cell Biol 2012; 14: 1295-304.
48. Pang R, Lee TK, Poon RT, et al. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 2007; 132: 1088-103.
49. Peloponese JM Jr, Yasunaga J, Kinjo T, et al. Peptidylproline cistrans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J Virol 2009; 83: 3238-48.
50. Jeong SJ, Ryo A, Yamamoto N. The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation. Biochem Biophys Res Commun 2009; 381: 294-9.
51. Guito J, Gavina A, Palmeri D, et al. The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcomaassociated herpesvirus from latency. J Virol 2014; 88: 547-58.
52. Ryo A, Togo T, Nakai T, et al. Prolyl-isomerase Pin1 accumulates in lewy bodies of parkinson disease and facilitates formation of alpha-synuclein inclusions. J Biol Chem 2006; 281: 4117-25.
53. Oh J, Malter JS, Pin1-FADD interactions regulate Fas-mediated apoptosis in activated eosinophils. J Immunol 2013; 190: 4937-45.
54. NDDICA (National Digestive Diseases Information Clearinghouse) (http://digestive. niddk. nih. gov/ddiseases/pubs/nash/).
55. Hennig L, Christner C, Kipping M, et al. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 1998; 37: 5953-60.
56. Bolton JL, Trush MA, Penning TM, et al. Role of quinones in toxicology. Chem Res Toxicol 2000; 13: 135-60.
57. Bayer E, Thutewohl M, Christner C, et al. Identification of hPin1 inhibitors that induce apoptosis in a mammalian Ras transformed cell line. Chem Commun (Camb) 2005; 4: 516-8.
58. Webb JL. Enzyme and Metabolic Inhibitors. Academic Press, New York (1966).
59. Chao SH, Greenleaf AL, Price DH. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res 2001; 29: 767-73.
60. Albert A, Lavoie S, Vincent M. A hyperphosphorylated form of RNA polymerase II is the major interphase antigen of the phosphoprotein antibody MPM-2 and interacts with the peptidyl-prolyl isomerase Pin1. J Cell Sci 1999; 112: 2493-500.
61. Xu YX, Hirose Y, Zhou XZ, et al. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev 2003; 17: 2765-76.
62. Fila C, Metz C, van der Sluijs P, Juglone inactivates cysteine-rich proteins required for progression through mitosis. J Biol Chem 2008; 283: 21714-24.
63. Quideau SP, Deffieux D, Douat-Casassus CL, et al. Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis. Angewandte Chemie International Edition, 2011; 50: 586-621.
64. Shiomi K, Yang H, Inokoshi J, et al. Pepticinnamins, new farnesylprotein transferase inhibitors produced by an actinomycete. II. Structural elucidation of pepticinnamin E. J Antibiot 1993; 46: 229-34.
65. Urusova DV, Shim JH, Kim DJ, et al. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev Res 2011; 4: 1366-77.
66. Shankar S, Ganapathy S, Srivastava RK, Green tea polyphenols: biology and therapeutic implications in cancer. Front Biosci 2007; 12: 4881-99.
67. Janowski B, Wöllner S, Schutkowski M, et al. A protease-free assay for peptidyl proryl cis/trans isomerases using standard peptide substrates. Anal Biochem 1997; 252: 299-307.
68. Neil GL, Niemann C, Hein GE. Structural specificity of alphachymotrypsin: polypeptide substrates. Nature 1966; 210: 903-7.
69. Fischer G, Bang H. The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase. Biochim Biophys Acta 1985; 828: 39-42.
70. Fischer G, Wittmann-Liebold B, Lang K, et al. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 1989; 337: 476-8.
71. Kofron JL, Kuzmic P, Kishore V, et al. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 1991; 30: 6127-34.
72. Uchida T, Takamiya M, Takahashi M, et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol 2003; 10: 15-24.
73. Fanghänel J, Akiyama H, Uchida C, et al. Comparative analysis of enzyme activities and mRNA levels of peptidyl prolyl cis/trans isomerases in various organs of wild type and Pin1-/-mice. FEBS Lett 2006; 580: 3237-45.
74. Tatara Y, Lin YC, Bamba Y, et al. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1. Biochem Biophys Res Commun 2009; 384: 394-8.
75. Mori T, Itami S, Yanagi T, et al. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors. J Biomol Screening 2009; 14: 419-24.
76. Schutkowski M, Bernhardt A, Zhou XZ, et al. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition. Biochemistry 1998; 37: 5566-75.
77. Uchida T, Furumai K, Fukuda T, et al. Prolyl isomerase Pin1 regulates mouse embryonic fibroblast differentiation into adipose cells. PLoS One 2012; 7: e31823.
78. Lee YM, Shin SY, Jue SS, et al. The role of PIN1 on odontogenic and adipogenic differentiation in human dental pulp stem cells. Stem Cells Dev 2014; 23: 618-30.
79. Ngo LT, Okogun JI, Folk WR, 21st century natural product research and drug development and traditional medicines. Nat Prod Rep 2013; 30: 584-92.
80. Mori T, Uchida T. Peptidyl Prolyl cis/trans Isomerase Inhibitors of small molecules. Current Enzyme Inhibition 2010; 6: 46-53.